评估初级保健药剂师的培训需求:在中国的一项横截面调查
Qingran Sun1, Yanan You1, Kejia Cao1
1National Medical Products Administration Key Laboratory for Drug Regulatory Innovation and Evaluation, China Pharmaceutical University, No. 639, Longmian Avenue, Jiangning District, Nanjing, 211198, Jiangsu Province, China.
BMC medical education
|March 14, 2025
概括
中国的初级保健药剂师需要更频繁,更相关的培训. 发展的关键领域包括临床药房,解决问题的技能和服务提供,重点是继续教育模式.
科学领域:
- 药房实践 在药房实践.
- 继续教育继续教育.
- 医疗保健劳动力发展工作人员
背景情况:
- 药剂师培训显著影响知识和技能,但全球存在差异.
- 中国的初级医疗保健工作者面临着有限的培训机会.
- 这项研究解决了了解中国初级保健药剂师培训的需要.
研究的目的:
- 探索中国初级保健药剂师目前的培训内容和方法.
- 确定这些专业人员中尚未满足的培训需求.
- 为未来的制药教育和培训战略提供信息.
主要方法:
- 采用多阶段抽样调查问卷调查.
- 收集的数据包括机构和药剂师的特点,培训状态和需求.
- 用描述性统计数据和配对的千-平方测试进行分析.
主要成果:
- 大多数药剂师拥有专业资格;收入和教育水平在不同地区不同.
- 显著的大多数 (67.9%) 接受培训不到一年.
- 现有和预期的培训内容和方法之间存在明显的差距,这表明有未满足的需求.
结论:
- 报告指出,中国初级保健医药专业培训的初步成功.
- 确定了培训的基本组成部分和未来的方向.
- 这些发现为加强药剂师在职培训和继续教育提供了基础.
更多相关视频
相关概念视频
Three-Compartment Open Model
117
The three-compartment open model is a pharmacokinetic model used to describe the distribution and elimination of drugs following extravascular administration. It comprises a central compartment representing the plasma and two peripheral compartments. The highly perfused peripheral compartment represents organs and tissues with a rich blood supply, such as the liver, kidneys, and lungs. The scarcely perfused peripheral compartment represents tissues with lower blood supply, such as adipose...
117
Analysis of Population Pharmacokinetic Data
208
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
208
Pharmacokinetic Models: Overview
538
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
538
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
54
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
54
Model Approaches for Pharmacokinetic Data: Compartment Models
68
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Two primary types of compartment models are recognized: mammillary and catenary. The more...
68
Pharmacovigilance
763
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
763


